| 000 | 01707 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513142626.0 | ||
| 264 | 0 | _c19980602 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarron, C P | |
| 245 | 0 | 0 |
_aA peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. _h[electronic resource] |
| 260 |
_bCancer research _cMay 1998 |
||
| 300 |
_a1930-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCorneal Neovascularization _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 | _aFibroblast Growth Factor 2 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercalcemia _xdrug therapy |
| 650 | 0 | 4 |
_aLeydig Cell Tumor _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aPhenylpropionates _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Vitronectin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSevere Combined Immunodeficiency _xdrug therapy |
| 700 | 1 | _aMeyer, D M | |
| 700 | 1 | _aPegg, J A | |
| 700 | 1 | _aEngleman, V W | |
| 700 | 1 | _aNickols, M A | |
| 700 | 1 | _aSettle, S L | |
| 700 | 1 | _aWestlin, W F | |
| 700 | 1 | _aRuminski, P G | |
| 700 | 1 | _aNickols, G A | |
| 773 | 0 |
_tCancer research _gvol. 58 _gno. 9 _gp. 1930-5 |
|
| 999 |
_c9548659 _d9548659 |
||